Reproduction toxicity of sertaconazole. Segment II (teratology) and Segment III (peri-postnatal toxicity).
The reproduction toxicity of 7-chloro-3-[1-(2,4-dichlorophenyl)-2- (1H-imidazol-1-yl)ethoxy-methyl]benzo[b]thiophene (sertaconazole, FI-7045, CAS 99592-32-2) (50, 100 and 150 mg/kg by oral route) has been investigated by performing two studies: the embryotoxicity or teratology study in rats and rabbits, and the peri-postnatal toxicity study in rats. According to the results obtained from the embryotoxicity studies, there was no maternal toxicity in either of the two species studied. The only embryofoetal abnormalities with statistical and toxicological significance were observed at the dose of 150 mg/kg in the teratology study on rabbits: hepatomegalia, pericardial oedema and peritoneal and hepatic haemorrhages. The results of the peri-postnatal study showed that the only maternal effect relating to the drug was an increase, proportional to the dose, in the weight of the ovaries, which was significant at the dose of 150 mg/kg. With reference to the offspring, only a reduction in the viability index at 150 mg/kg was observed. The non observed effects level (NOEL) for all three studies can be estimated at 100 mg/kg.
Romero
A
A
Research Centre, Ferrer Group, Barcelona, Spain.
Grau
M T
MT
Villamayor
F
F
Sacristán
A
A
Ortiz
J A
JA
D000375:Aging / Q000502:physiology; D000818:Animals; D000935:Antifungal Agents / Q000633:toxicity*; D001835:Body Weight / Q000187:drug effects; D005260:Female; D005333:Fetus / Q000187:drug effects; D007093:Imidazoles / Q000633:toxicity*; D008297:Male; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D012098:Reproduction / Q000187:drug effects*; D013723:Teratogens / Q000633:toxicity*; D013876:Thiophenes / Q000633:toxicity*
D000935:Antifungal Agents; D007093:Imidazoles; D013723:Teratogens; D013876:Thiophenes; C061131:sertaconazole